Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Department of Dermatology, National Cheng Kung University Hospital, Tainan, Taiwan.
J Eur Acad Dermatol Venereol. 2019 Jan;33(1):204-212. doi: 10.1111/jdv.15121. Epub 2018 Jul 6.
Oncologic treatments may lead to the development of paronychia, which may cause severe pain and disability. However, a detailed objective scoring system is lacking.
To develop an objective scoring system to quantify the severity of paronychia and also examine the correlation of this score with a pain index and patients' quality of life.
A novel scoring system for paronychia related to oncologic treatments (SPOT), consisting of four parameters, namely redness, oedema, discharge and granulation tissue, was designed to assess the severity of paronychia. The visual analogue scale (VAS) and Dermatology Quality of Life Index (DLQI) were recorded, and their association with the SPOT scores was analysed.
Ninety patients were enrolled from three medical centres in Taiwan. Severity of paronychia was determined by the scores of SPOT. Patients in the severe group had higher DLQI scores (severe vs. mild: P = 0.0018; severe vs. moderate: P = 0.0015). Both the DLQI and pain index scores were significantly higher in patients with higher dominant hand SPOT scores.
The SPOT scores demonstrated the association of the paronychia severity with DLQI and pain. It may thus be useful in clinical practice and future studies.
肿瘤治疗可能导致甲沟炎的发生，从而导致严重的疼痛和残疾。然而，目前缺乏详细的客观评分系统。
制定一种客观的评分系统来量化甲沟炎的严重程度，并研究该评分与疼痛指数和患者生活质量之间的相关性。
设计了一种新的与肿瘤治疗相关的甲沟炎客观评分系统（SPOT），该系统由四个参数组成，即发红、肿胀、溢液和肉芽组织，用于评估甲沟炎的严重程度。记录视觉模拟评分（VAS）和皮肤病生活质量指数（DLQI），并分析它们与 SPOT 评分的相关性。
从台湾的三家医疗机构共纳入 90 名患者。甲沟炎的严重程度由 SPOT 评分确定。严重组的 DLQI 评分更高（严重 vs. 轻度：P = 0.0018；严重 vs. 中度：P = 0.0015）。在 dominant hand SPOT 评分较高的患者中，DLQI 和疼痛指数评分均显著升高。
SPOT 评分显示了甲沟炎严重程度与 DLQI 和疼痛之间的关联。因此，它可能在临床实践和未来的研究中有用。
